HOME >> MEDICINE >> NEWS
January/February Annals of Family Medicine tip sheet

DY SHOWS
One of a cluster of five papers on depression in this issue of Annals, this study provides the first evidence that depression disease management produces increasingly better outcomes over time, while at the same time becoming less costly. For the study, practices providing enhanced care management supplemented acute care with systematic monitoring for two years, encouraging depressed patients to engage in active treatment and using practice nurses to provide regular care management. Analyzing the outcomes for 221 adults beginning treatment for major depression, the authors found that enhanced care significantly increased the number of days free of depression impairment for two years when compared to usual care (623 days vs. 527 days). The incremental cost-effectiveness ratio for enhanced care ranged from $5,054 to $8,073 per quality-adjusted life year. In their analysis, the authors point out that incremental quality-adjusted life years significantly increased with time while incremental costs declined. They conclude that enhanced management of depression in primary care is cost-effective and appears to be an efficient use of health care resources, and they assert that their findings should encourage health plans to provide for long- rather than short-term depression management. They note that primary care depression management results in comparable or greater cost-effectiveness than smoking cessation counseling, hypertension treatment, cholesterol treatment or chronic obstructive pulmonary disease rehabilitation.
Cost-Effectiveness of Enhancing Primary Care Depression Management on an Ongoing Basis
By Kathryn Rost, Ph.D., et al

****************************

OTHER STUDIES IN THIS ISSUE:

STUDY POINTS TO EARLIER ONSET OF TYPE 2 DIABETES
Analyzing data from the National Health and Nutrition Examination Survey, researchers found that over the course of a decade (1988 to 2000)
'"/>

Contact: Angela Lower
alower@aafp.org
913-906-6253
American Academy of Family Physicians
25-Jan-2005


Page: 1 2 3 4 5 6

Related medicine news :

1. March/April 2005 Annals of Family Medicine tip sheet
2. Annals of Internal Medicine tip sheet for March 15, 2005
3. Feb. 15, 2005, Annals of Internal Medicine tip sheet
4. Feb. 1, 2005, Annals of Internal Medicine tip sheet
5. Tip sheet Annals of Internal Medicine, Jan. 18, 2005
6. Tip sheet Annals of Internal Medicine, Jan. 4, 2005
7. Annals of Internal Medicine, tip sheet, Dec. 21, 2004
8. Dec. 7 tip sheet Annals of Internal Medicine
9. November/December 2004 Annals of Family Medicine tip sheet
10. Annals of Internal Medicine, tip sheet, Nov. 16, 2004
11. Annals of Internal Medicine tip sheet for Nov. 2, 2004

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: January February Annals Family Medicine tip sheet

(Date:5/23/2013)... Jim Fitzpatrick just did it again. The ... outside-of-the-box approach to reaching the retail automotive industry. With ... to the retail automotive industry, blending the immediacy of ... format. , CBTNews.com is an innovative website covering ... and Russell Brown host the show with videos, news ...
(Date:5/23/2013)... Coral Springs, FL (PRWEB) May 23, 2013 ... segment about redefining retirement. Many Americans are facing a dim ... stated the Late Boomers -- those born after 1955 -- ... credit card debt. But all hope for The Golden Years ... about how to reduce debt and keep earning after reaching ...
(Date:5/23/2013)... can cause rapidly progressing, life threatening meningitis and meningococcal ... have not known how it attaches to the human ... attaches to the airway to colonise", People can be ... while some people progress to invasive disease. To ... how the bacterium colonises the airway. Now that the ...
(Date:5/23/2013)... HealthDay Reporter , , WEDNESDAY, May 22 (HealthDay News) -- ... detecting lung cancer now have more information to help with ... finds that low-dose CT scans pick up significantly more lung ... history of smoking are at high risk for lung cancer, ... doctors have to consider the potential harm of radiation exposure ...
(Date:5/23/2013)... Los Angeles,Ca (PRWEB) May 23, 2013 ... with removing every sign associated with Rosacea. This condition ... skin and can affect a person’s self-image. Manufacturers have ... work to help constrict blood vessels near the surface ... and flushing. The new formula is available with special ...
Breaking Medicine News(10 mins):Health News:Fitzpatrick Advertising Founder Brings Auto Industry into Focus with CBT News 2Health News:Viewpoints with Terry Bradshaw Presents a Series on Redefining Retirement 2Health News:New discovery in fight against deadly meningococcal disease 2Health News:CT Scans Reduce Lung Cancer Deaths, Study Confirms 2Health News:CT Scans Reduce Lung Cancer Deaths, Study Confirms 3Health News:Revitol Rosacea Now Comes with Anti-Inflammatory Ingredients to Remove Redness and Flushing 2
(Date:5/23/2013)... 2013  Omeros Corporation (NASDAQ: OMER ... Application (IND) to evaluate OMS824 in Huntington,s disease ... Drug Administration (FDA). OMS824 selectively inhibits phosphodiesterase 10 ... brain linked to a wide range of diseases ... OMS824 has shown promising results in animal models ...
(Date:5/23/2013)... -- Echo Pharma Acquisition Limited ("Royalty Pharma") announced today that ... from 90 percent to 50 percent of Maximum Elan ... the terms of the Revised Offer Document issued today, ... the terms of the Increased Offer, Royalty Pharma is ... for $12.50 per share in cash. The Increased Offer ...
(Date:5/23/2013)... Engeland, May 23, 2013 Nederland ... met lagere urinewegsymptomen geassocieerd met BPH Astellas ... dochteronderneming van Astellas Pharma Inc, gebaseerd in ... kondigde vandaag aan dat het Nederlandse College ter Beoordeling ... in Nederland. De handelsvergunning verleend voor VESOMNI ...
Breaking Medicine Technology:Investigational New Drug Application Cleared by FDA for OMS824 in Huntington's Disease 2Investigational New Drug Application Cleared by FDA for OMS824 in Huntington's Disease 3Investigational New Drug Application Cleared by FDA for OMS824 in Huntington's Disease 4Royalty Pharma Reduces Acceptance Condition to 50% Plus One Share 2Royalty Pharma Reduces Acceptance Condition to 50% Plus One Share 3Royalty Pharma Reduces Acceptance Condition to 50% Plus One Share 4Royalty Pharma Reduces Acceptance Condition to 50% Plus One Share 5Royalty Pharma Reduces Acceptance Condition to 50% Plus One Share 6Royalty Pharma Reduces Acceptance Condition to 50% Plus One Share 7Royalty Pharma Reduces Acceptance Condition to 50% Plus One Share 8Royalty Pharma Reduces Acceptance Condition to 50% Plus One Share 9Royalty Pharma Reduces Acceptance Condition to 50% Plus One Share 10Astellas ontvangt handelsvergunning voor VESOMNITM van Nederlandse College ter Beoordeling van Geneesmiddelen 2Astellas ontvangt handelsvergunning voor VESOMNITM van Nederlandse College ter Beoordeling van Geneesmiddelen 3Astellas ontvangt handelsvergunning voor VESOMNITM van Nederlandse College ter Beoordeling van Geneesmiddelen 4
Cached News: